The possibility exists that as the company pushes hospitals to...

The possibility exists that as the company pushes hospitals to evaluate the kit for new indications, the body scrutinising the value of it may look closely at the evidence and actual cost benefit of their existing use and accounts. In other words they may revaluate the worth of the product based on their own experience as well as that of the literature and available trials. That could lead to a change in how much they use.It's not that unusual for a product to find that a new drug or treatment undergoes some reduction of use after the initial excitement and hype phase passes and finds a more mature level of use in the market based on actual experience and comparison of costs an benefits with other treatments.